• Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)

  • 2024/10/25
  • 再生時間： 10 分
  • ポッドキャスト

Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM).

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    続きを読む 一部表示

あらすじ・解説

Professor Sergio Harari joins us to discuss the results of a phase 2 clinical trial evaluating activity and safety of nintedanib in people with lymphangioleiomyomatosis (LAM).

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
続きを読む 一部表示
activate_buybox_copy_target_t1

Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。